← Back to all trials
Completed
NCT05601258
Lipase Levels and Coronavirus Disease 2019
Conditions: Pancreatitis, Lipase Increased
Enrollment: 4000
Sponsor: Uşak University
Location: Turkey
Summary
Although COVID-19 disease due to Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) affects the respiratory tract, heart and coagulation system, symptoms of gastrointestinal system involvement such as abdominal pain, nausea, vomiting and diarrhea are also common.In this study, it was aimed retrospective analysis of clinical and laboratory data of patients who developed pancreatic injury and acute pancreatitis in the course of COVID 19 disease.
Eligibility Criteria
Inclusion Criteria:Patients with lipase levels measured during COVID-19Exclusion Criteria:Patients with age <18 years Patients with pregnancy Patients whose lipase levels were not measured in the course of COVID-19 Patients with known solid organ malignacy Patients with known hematologic malignacy
Source: ClinicalTrials.gov (NCT05601258). StuddyBuddy aggregates publicly available trial information.